Relistor

Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor
Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan® And Relistor
Yahoo
Valeant Pharmaceuticals
drug reps
primary care
Relistor
Xifaxan
Flag link:
Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets
Yahoo
Valeant Pharmaceuticals
Progenics
Relistor
opioid-induced constipation
Flag link:
Earnings Preview: Is Valeant Set to Rise Based on Recent Wins?
Earnings Preview: Is Valeant Set to Rise Based on Recent Wins?
Market Realist
earnings
Valeant Pharmaceuticals
Relistor
brodalumab
Flag link:
Valeant Gets FDA OK for Anticonstipation Tablets Developed by Progenics
Valeant Gets FDA OK for Anticonstipation Tablets Developed by Progenics
WSJ Online
Valeant Pharmaceuticals
FDA
Progenics
Relistor
opiod-induced constipation
Flag link:
Top 3 Biotech Companies Awaiting FDA Approval
Top 3 Biotech Companies Awaiting FDA Approval
Investopedia
FDA
Pain Therapeutics
Durect Corporation
Remoxy
Progenics
Relistor
Flag link:
Valeant and Progenics Announce PDUFA Date Extension for Oral RELISTOR
Valeant and Progenics Announce PDUFA Date Extension for Oral RELISTOR
Yahoo
Valeant Pharmaceuticals
Progenics
FDA
Relistor
Flag link:
Pharma Events To Watch Out For This Week
Pharma Events To Watch Out For This Week
Bidness Etc.
Salix
Progenics
Relistor
AASLD
Merck
Gilead Sciences
AbbVie
Intercept Pharma
Flag link:
U.S. FDA advisors set to review opioid constipation drugs
U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Flag link:
Small Cap BioPharmas With Near-Term Catalysts
Small Cap BioPharmas With Near-Term Catalysts
Seeking Alpha
Amarin
Venaxis
Progenics
Celldex Therapeutics
Relistor
Vascepa
Flag link:
Salix, Progenics shares rise after FDA panel says it will review constipation drug Relistor
Salix, Progenics shares rise after FDA panel says it will review constipation drug Relistor
Yahoo/AP
FDA
Salix
Progenics
advisory panels
constipation
Relistor
Flag link:
Strong Relistor Sales Drive New Rally In Progenics
Strong Relistor Sales Drive New Rally In Progenics
Seeking Alpha
Progenics
Relistor
Salix
opioid-induced bowel dysfunction
Flag link:
Progenics Plummets On Rejection Of New Use Of Relistor Drug
Progenics Plummets On Rejection Of New Use Of Relistor Drug
Bloomberg
Progenics Pharmaceuticals
Relistor
Salix
opiod-induced constipation
Flag link:
Salix and Progenics Receive Complete Response Letter from FDA for Relistor sNDA
Salix and Progenics Receive Complete Response Letter from FDA for Relistor sNDA
Yahoo/BusinessWire
Progenics Pharmaceuticals
Salix
Relistor
opiod-induced constipation
constipation
Flag link:
Vivus, Onyx, Amarin Await Key Dates in July
Vivus, Onyx, Amarin Await Key Dates in July
Minyanville
Amarin
ONYX Pharmaceuticals
Vivus
Qnexa
AMR101
Arcalyst
Regeneron
Kyprolis
Salix
Relistor
Progenics Pharmaceuticals
Rayos
Roche
Lucentis
Horizon Pharma
Flag link:
FDA Action Date for Salix's Relistor
FDA Action Date for Salix's Relistor
Yahoo/Zacks.com
FDA
Salix
Relistor
Progenics Pharmaceuticals
Flag link:
Salix Pharma Says FDA Accepts SNDA Filing For RELISTOR For Non-Cancer Pain
Salix Pharma Says FDA Accepts SNDA Filing For RELISTOR For Non-Cancer Pain
RTT News
Relistor
Salix
FDA
painkiller
Flag link:
Possible New Indication for Progenics' Relistor Could Revive Its Fortunes
Possible New Indication for Progenics' Relistor Could Revive Its Fortunes
Seeking Alpha
Relistor
Progenics Pharmaceuticals
painkillers
Flag link:
Wyeth Quits On Relistor; Surprise Victory in First REMS Test Market
Wyeth Quits On Relistor; Surprise Victory in First REMS Test Market
InVivo
Wyeth
Relistor
Progenics Pharmaceuticals
Flag link:
Progenics Regains Relistor Rights
Progenics Regains Relistor Rights
TheStreet.com
Progenics Pharmaceuticals
Wyeth
Relistor
Flag link: